{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:57:49Z","timestamp":1718690269360},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,5]]},"DOI":"10.7759\/cureus.29952","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T15:50:25Z","timestamp":1664985025000},"source":"Crossref","is-referenced-by-count":1,"title":["Adverse Obstetric Outcomes in Pregnant Women Using Natalizumab for the Treatment of Multiple Sclerosis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Vaiishnavi","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins O","family":"Opara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana Yaqoob","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gargi","family":"Kabiraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humaira","family":"Kauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimee J","family":"Palakeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phani","family":"Chaduvula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanika","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smriti","family":"Lamsal Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56020049","article-title":"Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy's impact on disease activity","volume":"56","author":"Varyt\u0117 G","year":"2020","unstructured":"Varyt\u0117 G, Zakarevi\u010dien\u0117 J, Rama\u0161auskait\u0117 D, Lau\u017eikien\u0117 D, Arlauskien\u0117 A. Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy's impact on disease activity. Medicina (Kaunas). 2020, 56:49. 10.3390\/medicina56020049","journal-title":"Medicina (Kaunas)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S48618","article-title":"Optimal management of multiple sclerosis during pregnancy: current perspectives","volume":"4","author":"Borisow N","year":"2014","unstructured":"Borisow N, Paul F, D\u00f6rr J. Optimal management of multiple sclerosis during pregnancy: current perspectives. Degener Neurol Neuromuscul Dis. 2014, 4:111-20. 10.2147\/DNND.S48618","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517728813","article-title":"Natalizumab during pregnancy and lactation","volume":"24","author":"Proschmann U","year":"2018","unstructured":"Proschmann U, Thomas K, Thiel S, Hellwig K, Ziemssen T. Natalizumab during pregnancy and lactation. Mult Scler. 2018, 24:1627-34. 10.1177\/1352458517728813","journal-title":"Mult Scler"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09913-1","article-title":"A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project","volume":"267","author":"Lopez-Leon S","year":"2020","unstructured":"Lopez-Leon S, Geissb\u00fchler Y, Sabid\u00f3 M, Turkson M, Wahlich C, Morris JK. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project. J Neurol. 2020, 267:2721-31. 10.1007\/s00415-020-09913-1","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520917934","article-title":"Exposure to natalizumab during pregnancy and lactation is safe - no","volume":"26","author":"Airas L","year":"2020","unstructured":"Airas L. Exposure to natalizumab during pregnancy and lactation is safe - no. Mult Scler. 2020, 26:889-91. 10.1177\/1352458520917934","journal-title":"Mult Scler"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-021-01025-4","article-title":"Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy","volume":"47","author":"Godano E","year":"2021","unstructured":"Godano E, Barra F, Allodi A, et al.. Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy. Ital J Pediatr. 2021, 47:69. 10.1186\/s13052-021-01025-4","journal-title":"Ital J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.697974","article-title":"Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies","volume":"12","author":"Simone IL","year":"2021","unstructured":"Simone IL, Tortorella C, Ghirelli A. Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies. Front Neurol. 2021, 12:697974. 10.3389\/fneur.2021.697974","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514546790","article-title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","volume":"21","author":"Ebrahimi N","year":"2015","unstructured":"Ebrahimi N, Herbstritt S, Gold R, Amezcua L, Koren G, Hellwig K. Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Mult Scler. 2015, 21:198-205. 10.1177\/1352458514546790","journal-title":"Mult Scler"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518816614","article-title":"Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria","volume":"26","author":"Bsteh G","year":"2020","unstructured":"Bsteh G, Algrang L, Hegen H, et al.. Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria. Mult Scler. 2020, 26:69-78. 10.1177\/1352458518816614","journal-title":"Mult Scler"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005068","article-title":"Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks","volume":"90","author":"Portaccio E","year":"2018","unstructured":"Portaccio E, Moiola L, Martinelli V, et al.. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks. Neurology. 2018, 90:e832-9. 10.1212\/WNL.0000000000005068","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000723","article-title":"Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder","volume":"7","author":"Ciplea AI","year":"2020","unstructured":"Ciplea AI, Langer-Gould A, de Vries A, et al.. Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2020, 7:e723. 10.1212\/NXI.0000000000000723","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.209","article-title":"Natalizumab use during the third trimester of pregnancy","volume":"71","author":"Haghikia A","year":"2014","unstructured":"Haghikia A, Langer-Gould A, Rellensmann G, et al.. Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 2014, 71:891-5. 10.1001\/jamaneurol.2014.209","journal-title":"JAMA Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005067","article-title":"Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks","volume":"90","author":"Portaccio E","year":"2018","unstructured":"Portaccio E, Annovazzi P, Ghezzi A, et al.. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. Neurology. 2018, 90:e823-31. 10.1212\/WNL.0000000000005067","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0674-4","article-title":"Evaluation of pregnancy outcomes from the Tysabri\u00ae (natalizumab) pregnancy exposure registry: a global, observational, follow-up study","volume":"16","author":"Friend S","year":"2016","unstructured":"Friend S, Richman S, Bloomgren G, Cristiano LM, Wenten M. Evaluation of pregnancy outcomes from the Tysabri\u00ae (natalizumab) pregnancy exposure registry: a global, observational, follow-up study. BMC Neurol. 2016, 16:150. 10.1186\/s12883-016-0674-4","journal-title":"BMC Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96918-adverse-obstetric-outcomes-in-pregnant-women-using-natalizumab-for-the-treatment-of-multiple-sclerosis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:01Z","timestamp":1707507661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96918-adverse-obstetric-outcomes-in-pregnant-women-using-natalizumab-for-the-treatment-of-multiple-sclerosis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.29952","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,5]]}}}